Pages that link to "Q33894467"
Jump to navigation
Jump to search
The following pages link to Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America (Q33894467):
Displaying 50 items.
- Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection (Q24234875) (← links)
- Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children (Q24236693) (← links)
- Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush) (Q24243315) (← links)
- Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children (Q24244997) (← links)
- Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium (Q24630977) (← links)
- Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents (Q26863344) (← links)
- Antifungal resistance in pathogenic fungi (Q28208165) (← links)
- A Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis (Q30248908) (← links)
- Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants (Q30433993) (← links)
- Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants (Q30435365) (← links)
- Population pharmacokinetics of fluconazole in young infants (Q30439710) (← links)
- Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. (Q30452376) (← links)
- Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole (Q30452973) (← links)
- Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location (Q30452976) (← links)
- International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia (Q30453797) (← links)
- Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces (Q30799502) (← links)
- Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins (Q31058690) (← links)
- Candida pseudorugosa sp. nov., a novel yeast species from sputum (Q31064491) (← links)
- Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. (Q33183542) (← links)
- A first Portuguese epidemiological survey of fungaemia in a university hospital (Q33378325) (← links)
- Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer (Q33650105) (← links)
- Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia. (Q33938082) (← links)
- A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives. (Q33957538) (← links)
- Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species (Q33964454) (← links)
- Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome (Q33972828) (← links)
- Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent (Q33980499) (← links)
- Micafungin (Q33981019) (← links)
- Influence of liposomal amphotericin B on CD8 T-cell function (Q33982820) (← links)
- Use of antifungal drugs in pregnancy: a focus on safety (Q33983932) (← links)
- Iron acquisition from transferrin by Candida albicans depends on the reductive pathway (Q34033963) (← links)
- Urinary D-arabinitol/L-arabinitol levels in infants undergoing long-term antibiotic therapy (Q34073552) (← links)
- Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases (Q34105475) (← links)
- In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. (Q34109559) (← links)
- In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. (Q34142406) (← links)
- Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection (Q34142971) (← links)
- Fluconazole dose recommendation in urinary tract infection (Q34191338) (← links)
- Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility (Q34202154) (← links)
- Prophylactic antifungal therapy in the intensive care unit (Q34205622) (← links)
- Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor (Q34230759) (← links)
- Nosocomial candiduria: a review (Q34243460) (← links)
- Epidemiology of Candida species infections in critically ill non-immunosuppressed patients (Q34273626) (← links)
- Treatment of systemic fungal infections in older patients: achieving optimal outcomes (Q34273629) (← links)
- Management of Candida species infections in critically ill patients (Q34280580) (← links)
- Dermatologic infections in the immunocompromised (non-HIV) host (Q34305145) (← links)
- Vertebral osteomyelitis due to Candida species: case report and literature review (Q34312887) (← links)
- Fungal infections in older adults (Q34312894) (← links)
- Rationale for combination antifungal therapy (Q34335236) (← links)
- A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America (Q34335250) (← links)
- Host immune reactivity and antifungal chemotherapy: the power of being together. (Q34393835) (← links)
- Practice guidelines for the diagnosis and management of skin and soft-tissue infections (Q34460523) (← links)